CareDx
(NASDAQ) CDNA
CareDx Financials at a Glance
Market Cap
$1.44B
Revenue (TTM)
$412.82M
Net Income (TTM)
-$8.19M
EPS (TTM)
-$0.15
P/E Ratio
-180.73
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$28.82
Volume
1,646,950.797
Open
$27.85
Price
$28.82
Volume
1,646,950.797
Open
$27.85
Previous Close
$28.82
Daily Range
$27.76 - $29.07
52-Week Range
$10.96 - $29.07
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$28.82
Volume
1,646,950.797
Open
$27.85
Previous Close
$28.82
Daily Range
$27.76 - $29.07
52-Week Range
$10.96 - $29.07
Estimated Earnings Date
Aug 5, 2026
CDNA News
CDNA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CareDx
Industry
Biotechnology
Sector
Health CareEmployees
765
CEO
John W. Hanna, MBA
Website
www.caredx.comHeadquarters
South San Francisco, CA 94080, US
CDNA Financials
Key Financial Metrics (TTM)
Gross Margin
68.56%
Operating Margin
-3.20%
Net Income Margin
-1.98%
Return on Equity
-2.61%
Return on Capital
-6.38%
Return on Assets
-1.99%
Earnings Yield
-0.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.44B
Shares Outstanding
51.66M
Volume
1.65M
Avg. Volume
797.08K
Financials (TTM)
Gross Profit
$283.04M
Operating Income
-$13.20M
EBITDA
$10.70M
Operating Cash Flow
$72.95M
Capital Expenditure
-$7.76M
Free Cash Flow
$65.19M
Cash & ST Invst.
$187.18M
Total Debt
$24.50M
CareDx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$117.70M
+39.0%
Gross Profit
$84.07M
+49.4%
Gross Margin
71.43%
N/A
Market Cap
$1.44B
N/A
Market Cap/Employee
$2.23M
N/A
Employees
644
N/A
Net Income
$2.81M
+127.1%
EBITDA
$8.10M
+363.3%
Quarterly Fundamentals
Total Cash
$187.18M
-18.9%
Total Debt
$24.50M
-19.1%
Accounts Receivable
$44.59M
-37.6%
Inventory
$26.40M
+15.2%
Long Term Debt
$17.84M
-25.9%
Short Term Debt
$6.66M
+7.3%
Return on Assets
-1.99%
N/A
Return on Invested Capital
-3.98%
N/A
Free Cash Flow
$514.00K
+101.8%
Operating Cash Flow
$4.33M
+116.3%